Apr 13, 2026
Introducing Cancer Calculus: An exposé into the true cost of the world’s bestselling drug
Keytruda has been hailed as a game changer in cancer treatment, but much of the world can’t afford it. Now, a yearlong ICIJ investigation sheds new light on how pharmaceutical giant Merck has fended off competitors to keep the price of Keytruda sky-high, locking out patients and squeezing health care systems worldwide.



















